NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid...
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutics areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience and also offers treatments for parkinson's, alzheimer's disease.
I guess its stock can be down to $142 and below.
My trade...
Skew Inverse Head And Shoulders with a target of $174.65.
We do see bullish signals momentum wise where 7>21 >200.
Bullish
Let's just hope a bull market does kick in here as we enter the Christmas season with a Santa Rally.
Notes:
* Strong up trend on all time frames
* Great earnings track record
* Basing for the past ~8 months
* Now looking to come up on the right side of its base
* Printed a pocket pivot in the last session, indicating institutional buying
* Offering an early entry relative to its 50 day line
Technicals:
Sector: Healthcare - Drug Manufacturers -...
The PEAD projected a Neutral outlook for $ABBV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.
From B to C is not quite 61.8% retrace from flagpole high, but close enough.. B to C forms a nice bull flag, a continuation of primary trend. The breakout should occur at the mid line of the longer term upward channel. A 1.27 extension should give a target of 187 around Feb. 13 2023.
Healthcare (in addition to energy) is one of few sectors currently showing...
A price action above 138.00 supports a bullish trend direction.
Crossing below this level wil negate the bullish stance.
Consolidation price range between 140.00 to 144.00
Crossing above this level will assist the bullish trend to target 149.00
Crossing below 140.00 will be the first sign of pending weakness.
Betting on a further crash in AbbVie stock price. That huge candle preempts formal volatility switch. Fractally, hard to tell from this picture, possibly a start of a C in a WXY pattern.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with...
Neutral pattern.
ABBV pays a good yield and is still above the .382.
Possible inverse H&S inside the rectangle. If so the neckline in orange. If ABBV broke this line, a 100% move would take it to the top of the rectangle, or the resistance line.
EPS (FWD)
13.86
PE (FWD)
10.13
Div Rate (FWD)
$5.64
Yield (FWD)
4.02%
Short Interest
0.64%
Market Cap
$250.66B
No...
AbbVie Inc.
Idea: Long
Horizon: 1-2 months
Target: $145
Entry range: $143-145
Stop order: $141
Technical analysis
The share price has formed a short-term uptrend. If the local resistance level is broken through, there is a potential to move higher. Idea to increase the stock with the target of $145.
Fundamental factor
AbbVie is an American biopharmaceutical...
I am really liking @abbv right now. That's a nice support level and for the size of that candle it did not have a strong volume. In my opinion @ABBV is consolidating. It's creating a compression on that gray area. ORRRRR is creating and inverted Head And Shoulder? Green line
ANY THOUGHTS?
"This is only my personal opinion. I am not a trading/finance adviser"
$ABBV at top of channel, but still trending down. RSI and MACD starting to round and point downwards. I hope to catch 144.25 on a positive day for markets this week.
Entry: 144.25
TP: 123,62
SL: 150,6
Our AbbVie is trying to break out of the "Falling Wedge" pattern but is having a hard time.
Despite the pattern resistance being broken, momentum is weakening (MACD).
In addition, the volume is nearly average.
It is the opposite of what we want to see when we expect a breakout from a 222-day pattern.
It is probably due to bearish market sentiment.
Given the...
ATH 179.51
3 year low 62.55.
Yearly low 105.56
Earnings 10-28 BMO
No recommendation.
Strong stock with a good yield and is still above the .382 of the long trend up.
EPS (FWD)
13.86
PE (FWD)
10.39
Div Rate (FWD)
$5.64
Yield (FWD)
3.92%
Short Interest
0.64%
Market Cap
$254.71B
